---
id: mucormycosis-reverse-halo-sign_146
category: radiology
tags: [mucormycosis, reverse-halo-sign, atoll-sign, chest-radiology, CT, angioinvasive-fungi]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Mucormycosis - Reverse Halo Sign

**Q:** What is the reverse halo sign, and why does it occur in pulmonary mucormycosis? What is its differential diagnosis?

**A:**

## DEFINITION

**Reverse Halo Sign (Atoll Sign):** **"Ground-glass opacity surrounded by a ring of consolidation"**

**Appearance:** **"Doughnut" or "atoll" shape** (central ground-glass with peripheral consolidation ring)

**Key Point:** **Reverse halo sign in immunocompromised = mucormycosis** (until proven otherwise)

---

## PATHOPHYSIOLOGY IN MUCORMYCOSIS

**Mechanism:**

1. **Angioinvasion:** Mucor invades pulmonary blood vessels → vessel thrombosis
2. **Central infarction:** Ischemic necrosis → central ground-glass opacity (hemorrhage + necrosis)
3. **Peripheral viable tissue:** Organizing pneumonia at periphery → consolidation ring
4. **Result:** Ground-glass center + consolidation ring = reverse halo sign

**Key Point:** **Angioinvasion → central infarction** → reverse halo sign

---

## CT FINDINGS IN MUCORMYCOSIS

**Hallmark: Reverse Halo Sign + Angioinvasive Features**

### **Mnemonic: "MUCOR-ANGIO"**

**M**ultiple nodules (angioinvasive)
**U**nimmunocompromised (DM, neutropenia, steroids, transplant)
**C**entral ground-glass (hemorrhage, necrosis)
**O**utside consolidation ring (organizing pneumonia)
**R**everse halo sign (atoll sign)

**A**ngioinvasion (vessel thrombosis, infarction)
**N**odules with halo sign (may progress to reverse halo)
**G**round-glass center (infarction, hemorrhage)
**I**mmunocompromised host (DM, neutropenia, transplant)
**O**ften rapidly progressive (days to infarction)

**Key Point:** **Reverse halo + immunocompromised + DM = mucormycosis**

---

## TEMPORAL EVOLUTION

**Progression:**

**Day 0-3 (Early):**
- **Halo sign** (ground-glass halo around nodule - hemorrhage from angioinvasion)
- **Nodules** (single or multiple)

**Day 3-7 (Intermediate):**
- **Reverse halo sign develops** (central necrosis/infarction)
- **Ground-glass center** (hemorrhage + infarction)
- **Consolidation ring** (organizing pneumonia)

**Day 7-14 (Late):**
- **Air crescent sign** (cavitation, necrotic tissue separates)
- **Mass-like consolidation**
- **Wedge-shaped infarcts**

**Key Point:** **Halo sign → reverse halo → air crescent** (temporal progression)

---

## MUCORMYCOSIS-SPECIFIC FEATURES

**Additional CT Findings:**

**Mnemonic: "INFARCT"**

**I**nvasive (angioinvasive - vessel thrombosis)
**N**odules (multiple, bilateral)
**F**eeding vessel sign (vessel leading to nodule)
**A**ir crescent sign (late - cavitation)
**R**everse halo sign (organizing pneumonia pattern)
**C**onsolidation (wedge-shaped infarcts)
**T**hrombosis (pulmonary artery/vein occlusion)

**Key Point:** **Feeding vessel sign + reverse halo = angioinvasive fungus** (mucor, Aspergillus)

---

## RISK FACTORS FOR MUCORMYCOSIS

**Mnemonic: "DM-KETOACIDOSIS"**

**D**iabetes mellitus (DKA, poorly controlled) - **#1 risk factor**
**M**alignancy (hematologic - AML, lymphoma)

**K**etoacidosis (DKA - most common presentation)
**E**ndocrinopathy (uncontrolled DM)
**T**ransplant (hematopoietic stem cell > solid organ)
**O**rgan failure (renal, hepatic)
**A**cidosis (metabolic - DKA, uremia)
**C**irrhosis (iron overload)
**I**ron overload (hemochromatosis, deferoxamine)
**D**eferoxamine (siderophore - enhances Mucor growth)
**O**ncology (neutropenia, chemotherapy)
**S**teroids (high-dose, prolonged)
**I**mmunosuppression (calcineurin inhibitors)
**S**urgery/trauma (nosocomial)

**Key Point:** **DKA = #1 risk factor** for pulmonary mucormycosis

---

## DIFFERENTIAL DIAGNOSIS OF REVERSE HALO SIGN

**Mnemonic: "ORGANIZE FUNGI"**

**O**rganizing pneumonia (COP) - **most common cause** (50-60%)
**R**heumato (GPA/Wegener's - granulomatosis with polyangiitis)
**G**round-glass with consolidation ring
**A**ngioinvasive fungi (Mucor, Aspergillus)
**N**odular pattern (sarcoidosis)
**I**nfection (TB, Pneumocystis, bacterial)
**Z**oonotic (Q fever - Coxiella burnetii)
**E**osinophilic pneumonia

**F**ungal (Mucormycosis, Aspergillosis) - angioinvasive
**U**ncommon tumors (adenocarcinoma, lymphoma)
**N**on-infectious (organizing pneumonia, GPA)
**G**ranulomatosis with polyangiitis (GPA)
**I**nfarction (pulmonary infarct/embolism)

**Key Point:** **Reverse halo in immunocompetent = organizing pneumonia | Immunocompromised = fungal**

---

## CLINICAL PRESENTATION OF PULMONARY MUCORMYCOSIS

**Symptoms:**
- **Fever** (resistant to antibiotics)
- **Cough** (nonproductive or hemoptysis)
- **Chest pain** (pleuritic if infarction)
- **Dyspnea** (progressive, rapid)
- **Hemoptysis** (vascular invasion)

**Signs:**
- **DKA** (hyperglycemia, acidosis, Kussmaul respirations)
- **Rapid progression** (clinical deterioration over days)
- **Refractory to antibiotics** (not bacterial)

**Dissemination:**
- **Rhinocerebral** (most common - sinusitis → orbital → brain)
- **Pulmonary** (second most common)
- **Cutaneous** (post-trauma, burns)
- **Gastrointestinal** (rare)

**Key Point:** **DKA + hemoptysis + rapid progression = pulmonary mucormycosis**

---

## DIAGNOSIS

**Imaging:**
- **CT chest:** Reverse halo sign, nodules with halo, feeding vessel sign, wedge infarcts

**Microbiologic:**
- **BAL or biopsy:** Broad, ribbon-like, non-septate hyphae (branching at 90° angles)
- **GMS or PAS stain**
- **Culture:** Grows rapidly (1-3 days) on Sabouraud agar (white/gray fluffy colonies)

**Histopathology:**
- **Angioinvasion:** Hyphae invading blood vessel walls
- **Tissue necrosis:** Ischemic infarction
- **Minimal inflammation** (neutropenic host)

**Molecular:**
- **PCR** (serum, BAL) - not widely available
- **No serum antigen test** (unlike Aspergillus galactomannan)

**Key Point:** **Biopsy required** (BAL + GMS stain shows broad non-septate hyphae)

---

## TREATMENT

**Surgical Debridement + Antifungal + Correct Underlying Condition:**

**1. Antifungal Therapy:**
- **Liposomal amphotericin B** 5-10 mg/kg IV daily (first-line)
- **Posaconazole** 300mg PO/IV BID (day 1) → 300mg daily (salvage or step-down)
- **Isavuconazole** 200mg IV/PO TID (day 1) → 200mg daily (alternative)

**2. Surgical Debridement:**
- **Resect necrotic tissue** (lung, sinus, orbit)
- **Critical for survival** (antifungals cannot penetrate necrotic tissue)

**3. Correct Underlying Condition:**
- **Reverse DKA** (insulin, fluids, correct acidosis)
- **Reduce immunosuppression** (if possible)
- **Growth factors** (G-CSF for neutropenia)
- **Discontinue deferoxamine** (if on iron chelation)

**Duration:** 6-12 weeks (until resolved clinically and radiologically)

**Key Point:** **Liposomal amphotericin B + surgical debridement + reverse DKA** (all three essential)

---

## PROGNOSIS

**Mortality:**
- **Pulmonary mucormycosis: 50-70%** (even with treatment)
- **Disseminated: 80-100%**
- **Rhinocerebral: 50-80%**

**Predictors of Poor Outcome:**
- **Delayed diagnosis** (>7 days)
- **No surgical debridement**
- **Persistent neutropenia**
- **Persistent DKA/acidosis**
- **Disseminated disease**

**Key Point:** **Early diagnosis + aggressive surgery + liposomal amphotericin B = improved survival**

---

**Clinical Pearls:**
- **Reverse halo sign = ground-glass center + consolidation ring**
- **Reverse halo in immunocompromised = mucormycosis** (until proven otherwise)
- **DKA = #1 risk factor** for pulmonary mucormycosis
- **Angioinvasion → central infarction → reverse halo sign**
- **Temporal progression: Halo sign → reverse halo → air crescent**
- **Differential: Organizing pneumonia (immunocompetent), fungal (immunocompromised)**
- **Diagnosis: Biopsy + GMS stain** (broad, non-septate hyphae at 90° angles)
- **Treatment: Liposomal amphotericin B 5-10 mg/kg + surgical debridement + reverse DKA**
- **Mortality 50-70%** despite treatment (aggressive disease)
- **Feeding vessel sign = angioinvasive fungus** (Mucor, Aspergillus)

**Media:**

**Image 1 - Reverse Halo Sign (Mucormycosis):**

*CT chest showing the classic reverse halo sign (atoll sign): central ground-glass opacity surrounded by a ring of consolidation. Patient is a 45-year-old with poorly controlled diabetes presenting with DKA, fever, and hemoptysis. BAL with GMS stain revealed broad, non-septate hyphae consistent with mucormycosis. Required liposomal amphotericin B + surgical resection.*

**Image 2 - Temporal Evolution (Halo → Reverse Halo → Air Crescent):**

*Serial CT images demonstrating progression of angioinvasive fungal infection: (A) Day 2 - halo sign (ground-glass halo around nodule from hemorrhage). (B) Day 7 - reverse halo sign (central infarction with peripheral organizing pneumonia). (C) Day 14 - air crescent sign (cavitation as necrotic tissue separates).*

**Image 3 - Feeding Vessel Sign (Mucormycosis):**

*CT showing feeding vessel sign: pulmonary artery branch leading directly into a peripheral nodule (arrow). This sign indicates angioinvasive infection (mucormycosis or invasive aspergillosis). Patient with AML on chemotherapy, neutropenic. Biopsy confirmed mucormycosis.*

**Additional Resources:**
- **Radiopaedia.org:** Search "reverse halo sign," "mucormycosis," "atoll sign"
- **PMC articles:** Pulmonary mucormycosis imaging
- **IDSA Mucormycosis Guidelines 2019**

**Sources:** [Radiopaedia - Reverse Halo Sign], [IDSA Mucormycosis Guidelines 2019], [PMC - Angioinvasive fungal infections]
